Stefano Pessina: the alchemist turning drugs into gold

Over 50 years and more than 1,500 deals, Stefano Pessina turned a struggling family firm into an international healthcare giant. What’s his next target? Jane Lewis reports.

904-Passano-634
Stefano Pessina: a dealmaker, not a retailer

Stefano Pessina "has walked a long road" from his father's struggling pharmacy business in Naples to the top of the ladder of corporate America, says The Times. Last month, he "passed another milestone" when the conglomerate he built, Walgreens Boots Alliance a $64bn pharmaceutical retailer and wholesaler replaced General Electric as one of the 30 firms in the Dow Jones Industrial Average stockmarket index. It has taken Pessina, 77, about 50 years and a vast number of deals to achieve this feat. In the process, he has acquired a reputation as the "Italian alchemist" who turns "deals into gold".

On first impression, Pessina seems self-effacing to the point of chilliness, said Fortune in 2016. "The closest thing to a personal item" visible in his cheerless office in a dreary Chicago suburb is "one bottle of San Pellegrino water".

Perhaps that's because he actually lives in Monaco with his partner, Ornella Barra, whose company he acquired on an earlier spree and who still works alongside him. But another reason is that he "isn't interested in typical CEO activities" and readily admits as much. "I am not a retailer I am a team builder and a company builder," he says. Mention a deal, however, and "his eyes crackle with energy".

Pessina never planned to become a businessman. As a student of nuclear engineering at the prestigious Politecnico di Milano in the 1960s, he hoped to become an academic, but was turned off by academia's left-wing politics, says the Financial Times. After a stint with AC Nielsen, the market-research firm, his father set him the challenge of salvaging the family business a failing Naples-based pharma wholesaler. Pessina's "ability with numbers" came up trumps, says The Times. He repeated the trick for some of his father's business associates "in return for small stakes in their companies" and his deal-making career began.

Expanding into Europe and beyond

By 1977, when he'd combined some 150 small acquisitions into the newly named Alleanza Farmaceutica, Pessina begun venturing into France, Greece and Portugal. By the mid-1990s, the renamed Alliance Sant had made some 1,500 acquisitions. It wasn't all plain sailing: Pessina's hopes of building a pan-European pharma group was resisted in several countries. But, in 1997, he broke new ground in Britain acquiring Unichem, a publicly listed outfit with retail as wellas wholesale and distribution operations.

That gave him the scale to tilt still higher, says The Guardian. Having "stalked" the UK high-street chemist, Boots, for six years, Pessina landed his prize in 2006 after flamboyantly inviting the management "for merger talks on his yacht off Sardinia". A year later, he teamed up with private-equity firm KKR to take Alliance Boots private in a $22bn deal that was then Europe's largest leveraged buyout.

The Boots deal, which cast Pessina in the unflattering light of an international predator, was controversial not least for the debt burden placed on the company. "People thought we were mad but we ended up in a very nice spot," he observed last year. "Boots needed a lot of investment and a clear strategy." And it paved the way for him to cross the Atlantic and arrange to sell Alliance Boots to Walgreens in a £9bn deal.

He ended up as the largest shareholder in the merged firm, with a 14.4% stake (now worth around $9bn) and firm control of the reins. But he still isn't done his new preoccupation is cracking China. As he told Forbes in 2012: "My brain goes in just one direction: the future. I don't worry about the present."

Recommended

Peter Cowgill: the force behind a fashion phenomenon
People

Peter Cowgill: the force behind a fashion phenomenon

Peter Cowgill became the accountant for a small sports shop in the Pennines in the early 1980s. Now, JD Sports is one of the most formidable forces on…
23 Jan 2021
Christopher Columbus Wilson: the spiv who cashed in on new-fangled radios
Investment strategy

Christopher Columbus Wilson: the spiv who cashed in on new-fangled radios

Christopher Columbus Wilson gave radios away to drum up business in his United Wireless Telegraph Company. The company went bankrupt and Wilson was co…
21 Jan 2021
Elon Musk: the space oddity seeking world domination
People

Elon Musk: the space oddity seeking world domination

Elon Musk, the electric-car and space-travel pioneer who wants to move to Mars is now the world’s richest man. If he seems delusional, that’s all part…
16 Jan 2021
Great frauds in history: Philip Arnold’s big diamond hoax
Investment strategy

Great frauds in history: Philip Arnold’s big diamond hoax

Philip Arnold and his cousin John Slack lured investors into their mining company by claiming to have discovered large deposit of diamonds. There were…
13 Jan 2021

Most Popular

Why we won’t see a house-price crash in 2021
House prices

Why we won’t see a house-price crash in 2021

Lockdown sent house prices berserk as cooped up home-workers fled for bigger properties in the country. And while they won’t rise quite as much this y…
18 Jan 2021
Inflation is the easiest way out of this – just don’t expect politicians to admit it
Inflation

Inflation is the easiest way out of this – just don’t expect politicians to admit it

The UK government borrowed £34.1bn in December, a record amount for that month. Britain's debt pile now amounts to 100% of GDP. How are we going to pa…
22 Jan 2021
The best investment trusts to buy for 2021
Investment trusts

The best investment trusts to buy for 2021

Sectors ranging from emerging markets to student accommodation look poised to do well this year, says David Stevenson, as he picks the best investment…
19 Jan 2021